33 research outputs found
A Comparative Study of Cardiovascular Tolerability with Slow Extended Dialysis Versus Continuous Haemodiafiltration in the Critical Patient
Background: In the haemodynamically unstable patient the method of treatment of acute renal failure is still largely controversial. The purpose of our study was to compare slow extended dialysis with continuous
haemodiafiltration in the critical patient with indication for renal replacement therapy and haemodynamic
instability. Patients and Methods: This is a cohort study comparing in 63 ventilated critical patients a 12 month
period when only continuous haemodiafiltration was used (n=25) with an equal period of slow extended
dialysis (n=38). Our primary objective was to evaluate the impact of the dialytic procedure on cardiovascular
stability in those patients. As secondary aims we considered system coagulation/thrombosis and predictors
of mortality. In the two groups we analysed the first session performed, the second session performed and
the average of all the sessions performed in each patient. Results: In these patients, mortality in the
intensive care unit was high (68% in the continuous haemodiafiltration group and 63% in the slow extended
dialysis group). We did not find any association between the dialytic technique used and death; only
the APACHE score was a predictor of death. Slow extended dialysis was a predictor of haemodynamic
stability, a negative predictor of sessions that had to be interrupted for haemodynamic instability, and a
predictor of achieving the volume removal initially sought. Slow extended dialysis was also associated
with less coagulation of the system. Conclusions: Our data suggested that slow extended dialysis use was
not inferior to continuous haemodiafiltration use in terms of cardiovascular tolerability
Brugada syndrome is associated with scar and endocardial involvement: Insights from high-density mapping with the Rhythmia™ mapping system
The authors report the first catheter ablation of Brugada syndrome in the literature using the Rhythmia™ mapping system. Learning points include: (1) low voltage areas can be documented while mapping in some individuals, suggesting that Brugada syndrome may not be a pure ion channel disorder; (2) typical long fractionated potentials can also be identified in the endocardium, supporting the need to map the endocardium in all Brugada patients requiring ablation; (3) disappearance of the typical coved pattern following ablation does not necessarily predict cure, as the patient we present experienced ventricular fibrillation recurrence a few months later
Doença Mineral e Óssea (DMO) num Transplantado Renal
A 50-year-old post-menopausal recipient of a kidney allograft with bone pain, osteoporosis, persistent hypercalcaemia and elevated parathormone (PTH) levels, despite a satisfactory graft function, was treated
with bisphosphonates and cinacalcet starting, respectively, 5 and 6 months after renal transplantation (RT).
Sixteen months after treatment, there was improvement of bone mineral density (BMD) measured by dualenergy X-ray absorptiometry (DEXA). A bone biopsy was taken, unveiling a surprising and worrisome result.
Post-RT bone disease is different from classic CKD-MBD and should be managed distinctly, including, in some difficult cases, an invasive evaluation through the performance of a bone biopsy, as suggested in the KDIGO guidelines
Cardiac Computed Tomography Previous to Atrial Fibrillation Ablation - Effects of Technological Improvements and Protocol Optimization
Introdução: A capacidade de a TC cardíaca fornecer um mapa anatómico preciso e excluir a
presença de trombo intracardíaco é conhecida. O objetivo deste estudo foi avaliar o impacto
da otimização de protocolos e evolução tecnológica nas doses de radiação e contraste e na
qualidade de imagem dos exames de TC cardíaca prévia a ablação de fibrilhação auricular (FA).
Métodos: Registo prospetivo de doentes consecutivos de centro único, foram incluídos os que
fizeram TC cardíaca num contexto de avaliação prévia a ablação de FA (n = 270), distribuídos
em três grupos: Grupo 1, constituído pelos primeiros 150 doentes; Grupo 2, os últimos 60 doentes
feitos no mesmo aparelho; Grupo 3, os primeiros 60 doentes do novo aparelho. Avaliámos
a otimização do protocolo com base na dose de radiação, no volume de contraste, na necessidade
de aquisição complementar e na avaliação objectiva da qualidade de imagem (rácios
sinal/ruído, contraste/ruído e homogeneizac¸ão de densidade AE/AAE).
Resultados: Houve uma redução significativa da radiação entre cada um dos grupos e da dose
de contraste entre o primeiro e o último grupo (G1: 5,6 mSv e 100 ml; G2: 1,3 mSv e 90 ml;
G3: 0,6 mSv e 65 ml). Apesar das menores doses de radiação e contraste, o Grupo 3 apresentou
resultados significativamente melhores de qualidade de imagem (rácios sinal/ruído 13,5;
contraste/ruído 14,8; homogeneização de densidade 0,92).Conclusão: A otimização de protocolos e a evolução tecnológica permitiram reduções significativas nas doses de radiação e de contraste usadas na TC cardíaca pré-ablação de FA, sem prejudicar a qualidade de imagem.info:eu-repo/semantics/publishedVersio
Validating the predictive ability of the 2MACE score for major adverse cardiovascular events in patients with atrial fibrillation: results from phase II/III of the GLORIA-AF registry
The 2MACE score was specifically developed as a risk-stratification tool in atrial fibrillation (AF) to predict cardiovascular outcomes. We evaluated the predictive ability of the 2MACE score in the GLORIA-AF registry. All eligible patients from phase II/III of the prospective global GLORIA-AF registry were included. Major adverse cardiac events (MACEs) were defined as the composite outcome of stroke, myocardial infarction and cardiovascular death. Cox proportional hazards were used to examine the relationship between the 2MACE score and study outcomes. Predictive capability of the 2MACE score was investigated using receiver-operating characteristic curves. A total of 25,696 patients were included (mean age 71 years, female 44.9%). Over 3 years, 1583 MACEs were recorded. Patients who had MACE were older, with more cardiovascular risk factors and were less likely to be managed using a rhythm-control strategy. The median 2MACE score in the MACE and non-MACE groups were 2 (IQR 1-3) and 1 (IQR 0-2), respectively (p < 0.001). The 2MACE score was positively associated with an increase in the risk of MACE, with a score of & GE; 2 providing the best combination of sensitivity (69.6%) and specificity (51.6%), HR 2.47 (95% CI, 2.21-2.77). The 2MACE score had modest predictive performance for MACE in patients with AF (AUC 0.655 (95% CI, 0.641-0.669)). Our analysis in this prospective global registry demonstrates that the 2MACE score can adequately predict the risk of MACE (defined as myocardial infarction, CV death and stroke) in patients with AF. Clinical trial registration:. Unique identifiers: NCT01468701, NCT01671007 and NCT0193737
Gravidez e Diálise
A gravidez nas mulheres insuficientes renais crónicas tratadas com diálise é pouco frequente, mas tem aumentado nos últimos anos e o seu prognóstico tem melhorado. Uma gravidez bem-sucedida é mais frequente nas mulheres com função residual, sobretudo se a concepção ocorre antes de iniciar diálise ou se estão em diálise há menos de 1 ano. No entanto, numa doente com insuficiência renal moderada a grave, há risco de deterioração acelerada da função renal. Os resultados são semelhantes com ambas as modalidades de substituição da função renal, hemodiálise ou diálise peritoneal. A prescrição dialítica deve visar uma ureia inferior a 100mg/dl. As complicações maternas, que incluem hipertensão, anemia, perturbações do metabolismo fósfo-cálcico e deficits nutricionais, devem ser prevenidas e/ou tratadas atempadamente. A prematuridade e as perdas fetais são frequentes. A sobrevivência do recém-nascido e o bem-estar da mãe impõem a cooperação estreita entre médicos, enfermeiros e nutricionistas das áreas da obstetrícia, nefrologia e neonatologia
Gravidez na Transplantação Renal
Com a Transplantação Renal regista-se recuperação da fertilidade. A exposição a fármacos imunossupressores, como a prednisona, a ciclosporina, a azatioprina e o tacrolimus não está associada com um aumento da incidência de malformações congénitas. A Imunossupressão, particularmente com a ciclosporina, está relacionada com recém-nascidos com baixo peso ao nascer. Doentes transplantados têm um risco aumentado de complicações infecciosas, algumas com implicações importantes para o feto, como as infecções por citomegalovírus, herpes simples e toxoplasmose. Esta população tem uma maior frequência de prematuridade, variando a percentagem de nados vivos entre 70 e 100%. Impõe-se a manutenção de esforços continuados para identificar os factores de risco pré-gestacionais, optimizando as estratégias de abordagem neonatal para uma gravidez bem-sucedida
MRI-conditional pacemakers: current perspectives
António M Ferreira,1,2 Francisco Costa,2 António Tralhão,2 Hugo Marques,3 Nuno Cardim,1 Pedro Adragão1,2 1Cardiology Department, Hospital da Luz, 2Cardiology Department, Hospital Santa Cruz- CHLO, 3Radiology Department, Hospital da Luz, Lisbon, Portugal Abstract: Use of both magnetic resonance imaging (MRI) and pacing devices has undergone remarkable growth in recent years, and it is estimated that the majority of patients with pacemakers will need an MRI during their lifetime. These investigations will generally be denied due to the potentially dangerous interactions between cardiac devices and the magnetic fields and radiofrequency energy used in MRI. Despite the increasing reports of uneventful scanning in selected patients with conventional pacemakers under close surveillance, MRI is still contraindicated in those circumstances and cannot be considered a routine procedure. These limitations prompted a series of modifications in generator and lead engineering, designed to minimize interactions that could compromise device function and patient safety. The resulting MRI-conditional pacemakers were first introduced in 2008 and the clinical experience gathered so far supports their safety in the MRI environment if certain conditions are fulfilled. With this technology, new questions and controversies arise regarding patient selection, clinical impact, and cost-effectiveness. In this review, we discuss the potential risks of MRI in patients with electronic cardiac devices and present updated information regarding the features of MRI-conditional pacemakers and the clinical experience with currently available models. Finally, we provide some guidance on how to scan patients who have these devices and discuss future directions in the field. Keywords: pacemakers, magnetic resonance imaging, MRI, MRI-conditional devices, safet